Literature DB >> 28462702

Structure, Function, Involvement in Diseases and Targeting of 14-3-3 Proteins: An Update.

Ylenia Cau1, Daniela Valensin1, Mattia Mori1, Sara Draghi1, Maurizio Botta1.   

Abstract

14-3-3 is a class of proteins able to interact with a multitude of targets by establishing protein-protein interactions (PPIs). They are usually found in all eukaryotes with a conserved secondary structure and high sequence homology among species. 14-3-3 proteins are involved in many physiological and pathological cellular processes either by triggering or interfering with the activity of specific protein partners. In the last years, the scientific community has collected many evidences on the role played by seven human 14-3-3 isoforms in cancer or neurodegenerative diseases. Indeed, these proteins regulate the molecular mechanisms associated to these diseases by interacting with (i) oncogenic and (ii) pro-apoptotic proteins and (iii) with proteins involved in Parkinson and Alzheimer diseases. The discovery of small molecule modulators of 14-3-3 PPIs could facilitate complete understanding of the physiological role of these proteins, and might offer valuable therapeutic approaches for these critical pathological states. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  14-3-3; cancer; drug discovery; neurodegeneration; phosphorylation; protein-protein interaction; small molecules

Mesh:

Substances:

Year:  2018        PMID: 28462702     DOI: 10.2174/0929867324666170426095015

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  22 in total

Review 1.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

2.  14-3-3ζ protein protects against brain ischemia/reperfusion injury and induces BDNF transcription after MCAO in rat.

Authors:  Naeemeh Khalesi; Mojgan Bandehpour; Mohammad Reza Bigdeli; Hassan Niknejad; Ali Dabbagh; Bahram Kazemi
Journal:  J Appl Biomed       Date:  2019-04-15       Impact factor: 1.797

3.  Overexpression of 14-3-3ζ in lung tissue predicts an improved outcome in patients with lung adenocarcinoma.

Authors:  Man Li; Hailing Lu; Xiaolian Liu; Qingwei Meng; Yanbin Zhao; Xuesong Chen; Jing Hu; Wei Liu; Li Cai
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

4.  YWHAE as an HE4 interacting protein can influence the malignant behaviour of ovarian cancer by regulating the PI3K/AKT and MAPK pathways.

Authors:  Xiao Li; Caixia Wang; Shuang Wang; Yuexin Hu; Shan Jin; Ouxuan Liu; Rui Gou; Xin Nie; Juanjuan Liu; Bei Lin
Journal:  Cancer Cell Int       Date:  2021-06-09       Impact factor: 5.722

5.  Proteomics Approach of Rapamycin Anti-Tumoral Effect on Primary and Metastatic Canine Mammary Tumor Cells In Vitro.

Authors:  Patrícia F Lainetti; Antonio F Leis-Filho; Priscila E Kobayashi; Laíza S de Camargo; Renee Laufer-Amorim; Carlos E Fonseca-Alves; Fabiana F Souza
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

6.  Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII.

Authors:  Ylenia Cau; Daniela Vullo; Mattia Mori; Elena Dreassi; Claudiu T Supuran; Maurizio Botta
Journal:  Molecules       Date:  2017-12-22       Impact factor: 4.411

7.  SRARP and HSPB7 are epigenetically regulated gene pairs that function as tumor suppressors and predict clinical outcome in malignancies.

Authors:  Ali Naderi
Journal:  Mol Oncol       Date:  2018-04-16       Impact factor: 6.603

8.  Protective immunity induced by Eimeria common antigen 14-3-3 against Eimeria tenella, Eimeria acervulina and Eimeria maxima.

Authors:  Jianhua Liu; Lianrui Liu; Lingjuan Li; Di Tian; Wenyu Li; Lixin Xu; Ruofeng Yan; Xiangrui Li; Xiaokai Song
Journal:  BMC Vet Res       Date:  2018-11-12       Impact factor: 2.741

9.  Serum 14-3-3η protein is associated with clinical and serologic features of Sjögren's syndrome in patients with systemic lupus erythematosus: a cross-sectional analysis.

Authors:  Nevin Hammam; Nada M Gamal; Mona H Elzohri; Amira M Elsonbaty; Ahmed M Rashed; Zeiad H Eldaly; Dalia Tarik; Tamer A Gheita
Journal:  Clin Rheumatol       Date:  2020-03-23       Impact factor: 2.980

Review 10.  14-3-3: A Case Study in PPI Modulation.

Authors:  Alice Ballone; Federica Centorrino; Christian Ottmann
Journal:  Molecules       Date:  2018-06-08       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.